Anemia In Chronic Kidney Disease Patients On Dialysis Treated By New Form Of Intravenous Iron

Ferumoxytol, a novel intravenous form of iron that permits rapid administration of large doses, has been shown to be effective for treating iron deficiency in chronic kidney disease (CKD) patients on dialysis, according to a clinical trial appearing in the February 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The results indicate that this new agent may become an important treatment option for CKD patients.

More: continued here

Filed under: Blood on February 2nd, 2009